vs

Side-by-side financial comparison of Borealis Foods Inc. (BRLS) and RETRACTABLE TECHNOLOGIES INC (RVP). Click either name above to swap in a different company.

RETRACTABLE TECHNOLOGIES INC is the larger business by last-quarter revenue ($9.4M vs $7.1M, roughly 1.3× Borealis Foods Inc.). RETRACTABLE TECHNOLOGIES INC runs the higher net margin — -24.9% vs -53.2%, a 28.3% gap on every dollar of revenue. On growth, RETRACTABLE TECHNOLOGIES INC posted the faster year-over-year revenue change (4.0% vs -12.0%). Over the past eight quarters, RETRACTABLE TECHNOLOGIES INC's revenue compounded faster (11.5% CAGR vs -2.4%).

Borealis Foods Inc is a food technology enterprise specializing in developing and producing high-quality plant-based protein products including plant-based meat alternatives. It mainly serves retail and food service customers across North America and Europe, focusing on delivering affordable, nutritious sustainable food options matching the taste of conventional animal-derived meat.

Retractable Technologies Inc is a specialized medical device manufacturer that designs, manufactures and distributes safety-engineered disposable medical products, including retractable syringes, safety needles and IV catheters. Its key customers are healthcare facilities, pharmaceutical companies and public health agencies across North America and global markets, helping reduce needlestick injury risks for medical personnel and patients.

BRLS vs RVP — Head-to-Head

Bigger by revenue
RVP
RVP
1.3× larger
RVP
$9.4M
$7.1M
BRLS
Growing faster (revenue YoY)
RVP
RVP
+16.1% gap
RVP
4.0%
-12.0%
BRLS
Higher net margin
RVP
RVP
28.3% more per $
RVP
-24.9%
-53.2%
BRLS
Faster 2-yr revenue CAGR
RVP
RVP
Annualised
RVP
11.5%
-2.4%
BRLS

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
BRLS
BRLS
RVP
RVP
Revenue
$7.1M
$9.4M
Net Profit
$-3.8M
$-2.3M
Gross Margin
14.6%
-16.2%
Operating Margin
-27.1%
-81.7%
Net Margin
-53.2%
-24.9%
Revenue YoY
-12.0%
4.0%
Net Profit YoY
21.8%
-162.3%
EPS (diluted)
$-0.18
$-0.09

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BRLS
BRLS
RVP
RVP
Q4 25
$9.4M
Q3 25
$7.1M
$10.1M
Q2 25
$7.2M
$10.4M
Q1 25
$6.8M
$8.3M
Q4 24
$6.8M
$9.1M
Q3 24
$8.1M
$10.3M
Q2 24
$5.5M
$6.0M
Q1 24
$7.9M
$7.6M
Net Profit
BRLS
BRLS
RVP
RVP
Q4 25
$-2.3M
Q3 25
$-3.8M
$371.0K
Q2 25
$-4.6M
$-87.5K
Q1 25
$-4.2M
$-10.5M
Q4 24
$-5.8M
$3.8M
Q3 24
$-4.8M
$-1.9M
Q2 24
$-6.3M
$-14.2M
Q1 24
$-8.4M
$429.4K
Gross Margin
BRLS
BRLS
RVP
RVP
Q4 25
-16.2%
Q3 25
14.6%
16.7%
Q2 25
7.2%
-1.0%
Q1 25
13.1%
-0.0%
Q4 24
3.7%
-27.5%
Q3 24
15.8%
-0.1%
Q2 24
7.7%
-7.0%
Q1 24
3.1%
25.0%
Operating Margin
BRLS
BRLS
RVP
RVP
Q4 25
-81.7%
Q3 25
-27.1%
-36.2%
Q2 25
-46.7%
-49.1%
Q1 25
-42.6%
-56.4%
Q4 24
-68.4%
-79.6%
Q3 24
-44.8%
-49.6%
Q2 24
-94.8%
-95.6%
Q1 24
-88.3%
-39.3%
Net Margin
BRLS
BRLS
RVP
RVP
Q4 25
-24.9%
Q3 25
-53.2%
3.7%
Q2 25
-64.0%
-0.8%
Q1 25
-61.2%
-126.6%
Q4 24
-85.3%
41.6%
Q3 24
-59.8%
-18.6%
Q2 24
-115.0%
-234.9%
Q1 24
-106.8%
5.7%
EPS (diluted)
BRLS
BRLS
RVP
RVP
Q4 25
$-0.09
Q3 25
$-0.18
$0.01
Q2 25
$0.21
$0.00
Q1 25
$-0.20
$-0.35
Q4 24
$-0.82
$0.14
Q3 24
$-0.23
$-0.07
Q2 24
$0.29
$-0.48
Q1 24
$-0.49
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BRLS
BRLS
RVP
RVP
Cash + ST InvestmentsLiquidity on hand
$2.6M
Total DebtLower is stronger
$895.6K
Stockholders' EquityBook value
$-12.9M
$74.4M
Total Assets
$56.3M
$142.6M
Debt / EquityLower = less leverage
0.01×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BRLS
BRLS
RVP
RVP
Q4 25
$2.6M
Q3 25
$3.4M
Q2 25
$3.0M
Q1 25
$3.4M
Q4 24
$4.2M
Q3 24
$3.9M
Q2 24
$6.9M
Q1 24
$10.0M
Total Debt
BRLS
BRLS
RVP
RVP
Q4 25
$895.6K
Q3 25
Q2 25
Q1 25
Q4 24
$1.2M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
BRLS
BRLS
RVP
RVP
Q4 25
$74.4M
Q3 25
$-12.9M
$76.8M
Q2 25
$-9.2M
$76.5M
Q1 25
$-4.8M
$76.6M
Q4 24
$-695.9K
$87.2M
Q3 24
$5.1M
$83.5M
Q2 24
$9.9M
$85.4M
Q1 24
$16.2M
$99.7M
Total Assets
BRLS
BRLS
RVP
RVP
Q4 25
$142.6M
Q3 25
$56.3M
$146.4M
Q2 25
$57.3M
$147.1M
Q1 25
$58.4M
$149.3M
Q4 24
$60.0M
$160.7M
Q3 24
$61.9M
$157.8M
Q2 24
$63.6M
$160.7M
Q1 24
$70.3M
$176.0M
Debt / Equity
BRLS
BRLS
RVP
RVP
Q4 25
0.01×
Q3 25
Q2 25
Q1 25
Q4 24
0.01×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BRLS
BRLS
RVP
RVP
Operating Cash FlowLast quarter
$-190.6K
$-596.5K
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BRLS
BRLS
RVP
RVP
Q4 25
$-596.5K
Q3 25
$-190.6K
$-1.3M
Q2 25
$-2.2M
$-3.7M
Q1 25
$-1.4M
$-1.5M
Q4 24
$-819.4K
$-1.1M
Q3 24
$-3.3M
$-5.7M
Q2 24
$-4.2M
$-2.7M
Q1 24
$-6.8M
$-2.0M
Free Cash Flow
BRLS
BRLS
RVP
RVP
Q4 25
Q3 25
$-1.3M
Q2 25
$-4.1M
Q1 25
$-1.4M
$-1.6M
Q4 24
$-951.6K
$-1.4M
Q3 24
$-3.7M
$-6.5M
Q2 24
$-4.7M
$-2.8M
Q1 24
$-7.3M
$-2.2M
FCF Margin
BRLS
BRLS
RVP
RVP
Q4 25
Q3 25
-13.4%
Q2 25
-38.9%
Q1 25
-20.3%
-18.8%
Q4 24
-14.1%
-15.5%
Q3 24
-46.1%
-63.0%
Q2 24
-86.7%
-46.8%
Q1 24
-92.7%
-29.6%
Capex Intensity
BRLS
BRLS
RVP
RVP
Q4 25
Q3 25
0.9%
Q2 25
3.2%
Q1 25
0.2%
1.0%
Q4 24
2.0%
3.3%
Q3 24
5.6%
7.7%
Q2 24
9.4%
2.0%
Q1 24
7.0%
3.0%
Cash Conversion
BRLS
BRLS
RVP
RVP
Q4 25
Q3 25
-3.39×
Q2 25
Q1 25
Q4 24
-0.29×
Q3 24
Q2 24
Q1 24
-4.71×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons